Literature DB >> 25976345

Effect of common neuropathologies on progression of late life cognitive impairment.

Lei Yu1, Patricia A Boyle2, Sue Leurgans3, Julie A Schneider4, Richard J Kryscio5, Robert S Wilson6, David A Bennett7.   

Abstract

Brain pathologies of Alzheimer's (AD), cerebrovascular, and Lewy body diseases are common in old age, but the relationship of these pathologies with progression from normal cognitive function to the various stages of cognitive impairment is unknown. In this study, we fit latent Markov models from longitudinal cognitive data to empirically derive 3 latent stages corresponding to no impairment, mild impairment, and moderate impairment; then, we examined the associations of common neuropathologies with the rates of transition among these stages. Cognitive and neuropathological data were available from 653 autopsied participants in 2 ongoing cohort studies of aging who were cognitively healthy at baseline (mean baseline age 79.1 years) and had longitudinal cognitive data. On average, participants in these analyses developed mild impairment 5 years after enrollment, progressed to moderate impairment after an additional 3.4 years, and stayed impaired for 2.8 years until death. AD and chronic macroscopic infarcts were associated with a higher risk of progression to mild impairment and subsequently to moderate impairment. By contrast, Lewy bodies were associated only with progression from mild to moderate impairment. The 5-year probability of progression to mild or moderate impairment was 20% for persons without any of these 3 pathologies, 38% for AD only, 51% for AD and macroscopic infarcts, and 56% for AD, infarcts, and Lewy bodies. Thus, the presence of AD pathology alone nearly doubles the risk of developing cognitive impairment in late life, and the presence of multiple pathologies further increases this risk over multiple years before death.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Latent Markov model; Neuropathologies; Progression of cognitive impairment

Mesh:

Year:  2015        PMID: 25976345      PMCID: PMC4457559          DOI: 10.1016/j.neurobiolaging.2015.04.006

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  46 in total

1.  The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis.

Authors:  C Corpechot; F Carrat; A M Bonnand; R E Poupon; R Poupon
Journal:  Hepatology       Date:  2000-12       Impact factor: 17.425

2.  A battery of tests for assessing cognitive function in older Latino persons.

Authors:  Kristin R Krueger; Robert S Wilson; David A Bennett; Neelum T Aggarwal
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Oct-Dec       Impact factor: 2.703

3.  The dynamics of disease progression in sepsis: Markov modeling describing the natural history and the likely impact of effective antisepsis agents.

Authors:  M S Rangel-Frausto; D Pittet; T Hwang; R F Woolson; R P Wenzel
Journal:  Clin Infect Dis       Date:  1998-07       Impact factor: 9.079

4.  A random change point model for cognitive decline in Alzheimer's disease and mild cognitive impairment.

Authors:  Lei Yu; Patricia Boyle; Robert S Wilson; Eisuke Segawa; Sue Leurgans; Philip L De Jager; David A Bennett
Journal:  Neuroepidemiology       Date:  2012-07-17       Impact factor: 3.282

Review 5.  Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature.

Authors:  Peter T Nelson; Irina Alafuzoff; Eileen H Bigio; Constantin Bouras; Heiko Braak; Nigel J Cairns; Rudolph J Castellani; Barbara J Crain; Peter Davies; Kelly Del Tredici; Charles Duyckaerts; Matthew P Frosch; Vahram Haroutunian; Patrick R Hof; Christine M Hulette; Bradley T Hyman; Takeshi Iwatsubo; Kurt A Jellinger; Gregory A Jicha; Enikö Kövari; Walter A Kukull; James B Leverenz; Seth Love; Ian R Mackenzie; David M Mann; Eliezer Masliah; Ann C McKee; Thomas J Montine; John C Morris; Julie A Schneider; Joshua A Sonnen; Dietmar R Thal; John Q Trojanowski; Juan C Troncoso; Thomas Wisniewski; Randall L Woltjer; Thomas G Beach
Journal:  J Neuropathol Exp Neurol       Date:  2012-05       Impact factor: 3.685

6.  Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies.

Authors:  J A Schneider; Z Arvanitakis; L Yu; P A Boyle; S E Leurgans; D A Bennett
Journal:  Brain       Date:  2012-10       Impact factor: 13.501

7.  The natural history of cognitive decline in Alzheimer's disease.

Authors:  Robert S Wilson; Eisuke Segawa; Patricia A Boyle; Sophia E Anagnos; Loren P Hizel; David A Bennett
Journal:  Psychol Aging       Date:  2012-09-03

8.  Individual differences in rates of change in cognitive abilities of older persons.

Authors:  Robert S Wilson; Laurel A Beckett; Lisa L Barnes; Julie A Schneider; Julie Bach; Denis A Evans; David A Bennett
Journal:  Psychol Aging       Date:  2002-06

9.  Mild cognitive impairment: statistical models of transition using longitudinal clinical data.

Authors:  Erin L Abner; Richard J Kryscio; Gregory E Cooper; David W Fardo; Gregory A Jicha; Marta S Mendiondo; Peter T Nelson; Charles D Smith; Linda J Van Eldik; Lijie Wan; Frederick A Schmitt
Journal:  Int J Alzheimers Dis       Date:  2012-03-25

10.  Prevalence of mixed pathologies in the aging brain.

Authors:  Jasmin Rahimi; Gabor G Kovacs
Journal:  Alzheimers Res Ther       Date:  2014-11-21       Impact factor: 6.982

View more
  15 in total

Review 1.  Impact of multiple pathologies on the threshold for clinically overt dementia.

Authors:  Alifiya Kapasi; Charles DeCarli; Julie A Schneider
Journal:  Acta Neuropathol       Date:  2017-05-09       Impact factor: 17.088

2.  Neurofibrillary Tangle Stage and the Rate of Progression of Alzheimer Symptoms: Modeling Using an Autopsy Cohort and Application to Clinical Trial Design.

Authors:  Jing Qian; Bradley T Hyman; Rebecca A Betensky
Journal:  JAMA Neurol       Date:  2017-05-01       Impact factor: 18.302

Review 3.  Precision Medicine: Clarity for the Complexity of Dementia.

Authors:  Brenna Cholerton; Eric B Larson; Joseph F Quinn; Cyrus P Zabetian; Ignacio F Mata; C Dirk Keene; Margaret Flanagan; Paul K Crane; Thomas J Grabowski; Kathleen S Montine; Thomas J Montine
Journal:  Am J Pathol       Date:  2015-12-24       Impact factor: 4.307

Review 4.  Neuropsychological Assessment in Dementia Diagnosis.

Authors:  Sandra Weintraub
Journal:  Continuum (Minneap Minn)       Date:  2022-06-01

5.  Association of Cognition and Dementia With Neuropathologic Changes of Alzheimer Disease and Other Conditions in the Oldest-Old.

Authors:  Thomas J Montine; Maria M Corrada; Claudia Kawas; Syed Bukhari; Lon White; Lu Tian; Brenna Cholerton
Journal:  Neurology       Date:  2022-06-15       Impact factor: 11.800

6.  Transitions across cognitive states and death among older adults in relation to education: A multistate survival model using data from six longitudinal studies.

Authors:  Annie Robitaille; Ardo van den Hout; Robson J M Machado; David A Bennett; Iva Čukić; Ian J Deary; Scott M Hofer; Emiel O Hoogendijk; Martijn Huisman; Boo Johansson; Andriy V Koval; Maaike van der Noordt; Andrea M Piccinin; Judith J M Rijnhart; Archana Singh-Manoux; Johan Skoog; Ingmar Skoog; John Starr; Lisa Vermunt; Sean Clouston; Graciela Muniz Terrera
Journal:  Alzheimers Dement       Date:  2018-02-01       Impact factor: 21.566

7.  Distinct prion-like strains of amyloid beta implicated in phenotypic diversity of Alzheimer's disease.

Authors:  Mark Cohen; Brian Appleby; Jiri G Safar
Journal:  Prion       Date:  2016       Impact factor: 3.931

8.  Longitudinal Modeling of Functional Decline Associated with Pathologic Alzheimer's Disease in Older Persons without Cognitive Impairment.

Authors:  Dai Wang; Tim Schultz; Gerald P Novak; Susan Baker; David A Bennett; Vaibhav A Narayan
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 9.  Religious Orders Study and Rush Memory and Aging Project.

Authors:  David A Bennett; Aron S Buchman; Patricia A Boyle; Lisa L Barnes; Robert S Wilson; Julie A Schneider
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

10.  A Bayesian hierarchical change point model with parameter constraints.

Authors:  Hong Li; Andreana Benitez; Brian Neelon
Journal:  Stat Methods Med Res       Date:  2020-09-13       Impact factor: 3.021

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.